Countries Japan
Asahi Kasei Bioprocess and Axolabs Partner to Boost Oligonucleotide Therapy Development
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide ...
April 12, 2024 | News
Nanoform Finland Plc Partners with CBC Co., Ltd. to Transform Japanese Pharmaceutical Industry with Nanotechnology
Nanoform Finland Plc ("Nanoform") announced a strategic partnership whereby CBC Co., Ltd. ("CBC"), will utilize its extensive experience in the Japan...
April 12, 2024 | News
ACROBiosystems Debuts 3D Organoid Solutions for Biotherapeutic Research
ACROBiosystems has been continuously rolling out a series of innovative organoid-related products. At a range of significant international events, includin...
April 11, 2024 | News
Eisai and Biogen Seek FDA Approval for Monthly Alzheimer's Treatment Dosing
Eisai Co., Ltd. and Biogen Inc. have taken a significant step forward in the fight against Alzheimer’s disease by submitting a Supplemental Biologics...
April 01, 2024 | News
Resonance Health Joins Forces with Micron, Inc. for Strategic Entry into Japan's Healthcare Sector
Resonance Health Ltd, listed on the Australian Securities Exchange (ASX) under the ticker RHT, has officially announced its strategic move into the Japanes...
March 28, 2024 | News
Takeda Receives FDA Approval for ICLUSIG as a First-Line Treatment in Ph+ ALL
Takeda Receives FDA Approval for ICLUSIG as a First-Line Treatment in Ph+ ALL Takeda Pharmaceutical Company Limited (TSE: 4502; NYSE: TAK) is plea...
March 25, 2024 | News
Takeda Achieves Groundbreaking FDA Approval for ICLUSIG® in Treating Newly Diagnosed Ph+ ALL Patients
This approval marks a pioneering step in treating adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) ALL, offering a combination th...
March 20, 2024 | News
Ajinomoto Bio-Pharma Services Sweeps CDMO Leadership Awards in Unprecedented Six-Category Win
Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, received CDMO Le...
March 13, 2024 | News
Ono Pharmaceutical Forms Strategic Alliance with Harvard University for Drug Discovery
Ono Pharmaceutical announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University&nbs...
March 12, 2024 | News
Eisai Boosts Support for Alzheimer's Diagnosis with $15 Million Investment in C2N Diagnostics
Eisai Co., Ltd. announced a significant step forward in the fight against Alzheimer's disease (AD) today, with its U.S. subsidiary Eisai Inc. committing up...
March 07, 2024 | News
MGI Tech & Juntendo University: Transforming Care for Rare Disease Patients
While they are identified and addressed differently around the world, there are over known 6,000 rare diseases – characterized by a wide range of dis...
February 29, 2024 | News
Ono Pharmaceutical Partners with InveniAI to Revolutionize Drug Discovery Using AI
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") has announced a strategic partnership with the AI-driven company InveniAI...
February 22, 2024 | News
Japan Accelerates Approval Process for Groundbreaking Urothelial Cancer Treatment by Astellas
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") announced that Japan's Ministry of Health, Labour a...
February 19, 2024 | News
Japan Becomes First in the World to Approve Dupixent® for Chronic Spontaneous Urticaria (CSU)
Approval based primarily on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth appr...
February 17, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
